Blocknomi
Key Takeaways Moderna shares climbed over 16% following the publication of Phase 3 data in the New England Journal of Medicine demonstrating that its mRNA flu vaccine (mRNA-1010) surpassed a…
Related articles
-
Alphabet (GOOGL) Stock Surges as J.P. Morgan Declares It Their Premier Investment Choice Following Stellar Q1
Blocknomi Published 04.05.2026 17:56
-
Nexo adds 0% credit lines for Solana and XRP holders
Crypto.News Published 30.04.2026 14:13
-
How to choose a safe DeFi platform before you deposit in 2026
CryptoSlate Published 06.05.2026 17:00
-
New York secures $5M from Uphold over CredEarn promotion
Crypto.News Published 03.05.2026 08:50
-
GSR gains SC Ventures backing for institutional crypto market push
Crypto.News Published 05.05.2026 06:30
-
How SHRMiner AI cloud mining is reshaping how to easily earn $9,997 in passive income in 2026
Crypto.News Published 05.05.2026 16:17
-
CoinDesk 20 performance update: Stellar (XLM) drops 1.7% as index moves lower
CoinDesk Published 28.04.2026 13:19
-
Real Finance Blockchain Guide: Unlocking Real-World Asset Yield in DeFi
CryptoPotato Published 30.04.2026 15:50